ELOVL5 and hepatocellular carcinoma: We found that the expression levels of eight genes, namely, CYP7A1, AKR1C3, DAGLA, ACLY, ACACA, BRCA1, MAPK3, and ELOVL5 were increased in LIHC and that their upregulation were indicated a poor prognosis in patients with HCC (Fig. 6A, B).